Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C.

被引：0
|
作者：
Kasahara, A
Hayashi, N
Sasaki, Y
Kakumu, S
Kiyosawa, K
Okita, K
机构：
[1] Osaka Univ, Suita, Osaka, Japan
[2] Aichi Med Coll, Nagoya, Aichi, Japan
[3] Shinshu Univ, Matsumoto, Nagano 390, Japan
[4] Yamaguchi Univ, Ube, Yamaguchi 755, Japan
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
807
引用
收藏
页码：361A / 361A
页数：1
相关论文
共 50 条
  • [31] Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapy
    Hung, Chao-Hung
    Lee, Chuan-Mo
    Wang, Jing-Houng
    Hu, Tsung-Hui
    Chen, Chien-Hung
    Lin, Chih-Yun
    Lu, Sheng-Nan
    INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (10) : 2344 - 2352
  • [32] Hepatocellular carcinoma development in sustained viral responders to interferon therapy in patients with chronic hepatitis C
    Enokimura, N
    Shiraki, K
    Kawakita, T
    Saitou, Y
    Inoue, H
    Okano, H
    Yamamoto, N
    Deguchi, M
    Sakai, T
    Ohmori, S
    Fujikawa, K
    Murata, K
    Niki, Y
    Nakano, T
    ANTICANCER RESEARCH, 2003, 23 (1B) : 593 - 596
  • [33] Effect of lifestyle modification on hepatocellular carcinoma incidence and mortality among patients with chronic hepatitis B
    Park, Yewan
    Kang, Danbee
    Sinn, Dong Hyun
    Kim, Hyunsoo
    Hong, Yun Soo
    Cho, Juhee
    Gwak, Geum-Youn
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (24) : 3843 - 3854
  • [34] Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C
    Kasahara, A
    Hayashi, N
    Mochizuki, K
    Takayanagi, M
    Yoshioka, K
    Kakumu, S
    Iijima, A
    Urushihara, A
    Kiyosawa, K
    Okuda, M
    Hino, K
    Okita, K
    HEPATOLOGY, 1998, 27 (05) : 1394 - 1402
  • [35] Effect of lifestyle modification on hepatocellular carcinoma incidence and mortality among patients with chronic hepatitis B
    Yewan Park
    Danbee Kang
    Dong Hyun Sinn
    Hyunsoo Kim
    Yun Soo Hong
    Juhee Cho
    Geum-Youn Gwak
    World Journal of Gastroenterology, 2023, (24) : 3843 - 3854
  • [36] Combination therapy with interferon α and β to chronic hepatitis C.
    Horilke, N
    Michitaka, K
    Masumoto, T
    Yamamoto, K
    Yamauchi, Y
    Kojima, N
    Onjl, M
    HEPATOLOGY, 1998, 28 (04) : 373A - 373A
  • [37] The effect of interferon therapy on alpha-fetoprotein levels in patients with chronic hepatitis C.
    Gochu, J
    Mirza, A
    Kaur, S
    Ganger, D
    Rosenblate, H
    Jensen, D
    HEPATOLOGY, 1996, 24 (04) : 1084 - 1084
  • [38] Effect of Response to Interferon-α Therapy on the Occurrence of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
    Lee, Danbi
    Chung, Young-Hwa
    Lee, Sae Hwan
    Kim, Sung Eun
    Lee, Yoon-Seon
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Lee, Yung Sang
    Yu, Eunsil
    DIGESTIVE DISEASES, 2012, 30 (06) : 568 - 573
  • [39] Effects of interferon therapy on incidence of hepatocellular carcinoma in chronic liver diseases C
    Muta, R
    Fujiyama, S
    Tanaka, M
    Sugi, K
    Chikazawa, H
    Honda, Y
    Maeda, S
    Shibata, J
    Iida, S
    Araki, K
    Akahoshi, M
    Sagara, K
    Tomita, K
    GASTROENTEROLOGY, 1997, 112 (04) : A1341 - A1341
  • [40] The prevention of hepatocellular carcinoma by the method of interferon therapy for chronic type C hepatitis
    Arase, Y
    Kumada, H
    PROGRESS IN HEPATOLOGY, VOL 3: HEPATOCELLULAR CARCINOMA, 1997, 1142 : 53 - 58
12345